Minister Champagne announces construction of NRC’s vaccine plant in Montreal is complete, Concordia gets go-ahead for a new school of interdisciplinary health, NISC receives quantum research funding to improve online communication security, and more.
Topic: critical products for COVID-19
NGen joins $10-million effort to bolster manufacturing capacity for a COVID-19 vaccine
The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.